Skip to main content

NACFC Main banner

Icon Legend

Food/Drinks Available

CE's Available

Reception

Pre-registration Required

Livestreaming

Recorded Session

Back

Tweet this

Paul Robinson

Poster(s):

(693) A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 2 Through 5 Years of Age with Cystic Fibrosis and at Least One F508del Allele
Thursday, November 3, 2022
12:45 PM – 1:25 PM ET